Evidence map›Paper›PMID 36726645›Full record

ArticleFrontiers in cellular and infection microbiology2022

Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of

Surafel K Tebeje, Wakweya Chali, Elifaged Hailemeskel, Jordache Ramjith, Abrham Gashaw, Temesgen Ashine, Desalegn Nebret, Endashaw Esayas, Tadele Emiru, Tizita Tsegaye and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 6 countries.

Surafel K TebejeArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Wakweya ChaliArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Elifaged HailemeskelArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Jordache RamjithDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Abrham GashawArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Temesgen AshineArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Desalegn NebretArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Endashaw EsayasArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Tadele EmiruArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Tizita TsegayeArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Karina TeelenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Kjerstin LankeDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Eizo TakashimaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Takafumi TsuboiDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Nichole D SalinasLaboratory of Malaria Immunology and Vaccinology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States.
Niraj H ToliaLaboratory of Malaria Immunology and Vaccinology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States.
David NarumLaboratory of Malaria Immunology and Vaccinology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States.
Chris DrakeleyLondon School of Hygiene & Tropical Medicine, London, United Kingdom.
Benoit WitkowskiMalaria Molecular Epidemiology Unit, Pasteur Institute of Cambodia, Phnom Penh, Cambodia.
Amelie VantauxMalaria Molecular Epidemiology Unit, Pasteur Institute of Cambodia, Phnom Penh, Cambodia.
Matthijs M JoreDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
William J R StoneLondon School of Hygiene & Tropical Medicine, London, United Kingdom.
Ivo S HansenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Fitsum G TadesseArmauer Hansen Research Institute, Malaria and Neglected Tropical Disease Directorate, Addis Ababa, Ethiopia.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Armauer Hansen Research Institute · ETRadboud University Medical Center · NLRadboud University Nijmegen · NLEhime University · JPInstitut Pasteur du Cambodge · KHLondon School of Hygiene & Tropical Medicine · GBNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Wellcome TrustWellcome Trust 218676/Z/19/Z
6 · The paper itself

Abstract

Naturally acquired antibodies may reduce the transmission of

Indexed as

AnophelesMalariaMalaria, VivaxAnimalsAntibodies, ProtozoanHumansPlasmodium falciparumPlasmodium vivaxAntibodies, ProtozoananophelesgametocyteimmunitymalariaPlasmodium vivaxtransmissiontransmission-blockingvaccine

Identifiers

PMID36726645
PMCPMC9885094
OpenAlexW4316363457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.